Medications like Ozempic, Wegovy, or their compounded parts Semaglutide, and Tirzepatide originally developed to treat diabetes and obesity, are now showing potential for preventing certain types of cancer. These drugs,
Continue readingGLP-1 Drugs Like Semaglutide and Tirzepatide May Help Reduce Cancer Risk
GLP-1 drugs, such as Ozempic, Wegovy, and Mounjaro, or the compounded versions Tirzepatide and Semaglutide have long been used to treat diabetes and aid in weight loss. However, new research
Continue readingGLP-1 Drugs Could Prevent 34,000 Heart Attacks and Strokes Each Year
GLP-1 receptor agonists like Ozempic and Wegovy have proven to be effective in weight loss, backed by significant scientific data. However, these medications can be expensive and sometimes hard to
Continue readingDo ‘Natural GLP-1 Supplements’ Work As Well As Ozempic?
A new Cleveland Clinic study has revealed key factors that influence long-term weight loss in people using GLP-1 receptor agonist (RA) medications like semaglutide (Wegovy, Ozempic) and liraglutide (Saxenda, Victoza).
Continue readingWith Everything Worth Fighting For, Persistence is Key!
In a groundbreaking clinical trial, the active ingredient in the popular weight loss medication Zepbound, known as tirzepatide, has been shown to reduce the risk of developing type 2 diabetes
Continue readingTirzepatide Dramatically Lowers Type 2 Diabetes Risk 94%